THE MINISTER OF STATE IN THE MINISTRY OF COMMERCE AND INDUSTRY (INDEPENDENT CHARGE) (SMT. NIRMALA SITHARAMAN)
a.) Total quantity and the value of medicines in the category of ayush products, medicinal herbs etc, county-wise during the last three years is as follows :
EXPORT OF MEDICINES 2011-12 2012-13 2013-14 QTY(KGS) VAL(US $ M) QTY(KGS) VAL(US $ M) QTY(KGS) VAL(US $ M) 57032768 500.494879 70623851 528.356248 73064731 498.953358 EXPORT OF MEDICINES FOR TOP TEN DESTINATION OF THE WORLD 2011-12 2012-13 2013-14 COUNTRY VAL(US $ M) COUNTRY VAL(US $ M) COUNTRY VAL(US $ M) U S A 114.79 U S A 182.58 U S A 155.20 RUSSIA 40.44 JAPAN 33.75 PAKISTAN IR 29.20 JAPAN 32.20 PAKISTAN IR 31.15 GERMANY 28.64 MEXICO 27.17 GERMANY 29.25 JAPAN 25.11 PAKISTAN IR 26.89 U ARAB EMTS 19.41 AUSTRALIA 22.12 GERMANY 22.62 RUSSIA 15.12 U ARAB EMTS 21.81 U ARAB EMTS 20.53 MEXICO 15.01 NEPAL 14.64 EGYPT A RP 12.76 AUSTRALIA 11.68 RUSSIA 11.72 NEPAL 11.53 NEPAL 10.77 ITALY 10.55 FRANCE 11.05 ITALY 9.36 FRANCE 10.25 OTHER 180.52 OTHER 170.27 OTHER 169.71 COUNTRIES COUNTRIES COUNTRIES TOTAL 500.49 TOTAL 528.36 TOTAL 498.95
b) The export of medicines in the category of ayush products, medicinal herbs etc. for the year 2013-14 is USD 498.95 million, a growth rate of about -6% as compare to year 2012-13 which was USD 528.36 million. Following reasons could be attributed to the declining growth rate.
1) Changes in the global Regulatory requirements.
2) Changing Demand and supply requirements in overseas markets. Few countries have started cultivating the herbs in-house and developing herbal medicines and Dietary Supplements.
3) Increasing transaction costs and Dollar fluctuations.
4) Changes in the acceptance levels of our products in overseas markets due to new cultivation practices/quality standards/certifications.
c) The demand for Indian herbs, ayurvedic and herbal medicines is growing in the European Union. India’s exports of herbs, ayurvedic and herbal medicines to the European Union for the year 2013-14 is to the tune of USD 65 million (as against USD 54 million in the year 2012-13) growing @ 20%. However, exports to the other developed countries like USA, Canada & Japan are showing slight decline in exports for the year 2013-14.
d) FDI upto 100% under Government route in Brownfield Pharma and under automatic route in Greenfield Pharma is permitted. Further FIPB at the time of grant of approval of FDI in Brownfield Pharma also imposes following conditions:-
(i) The production level of consumables and NLEM drugs and their supply to domestic market : at the time of induction of FDI, be maintained over the next five years at an absolute quantitative level. The benchmark for this level would be decided with reference to the level of production of consumables and /or NLEM drugs in the immediately preceding three financial years to the year of induction of FDI. Of these, the highest level of production in any of these three years would be taken as the level;
(ii) R&D expenses be maintained in value terms for 5 years at an absolute quantitative level at the time of induction of FDI. The benchmark for this level would be decided with reference to the highest level of R&D expenses which has been incurred in any of the three financial year immediately preceding to the year of induction of FDI; and
(iii) The administrative ministries concerned and the FIPB secretariat will be provided complete information pertaining to the transfer of technology, if any, along with induction of foreign investment into the investee company.
e) Some of the measures taken by the Government for encouraging export from India are:-
# Awarding of Ayush Marks for Quality Certification and recognitions for AYUSH products in international Market.
# Voluntary certification of quality of Ayurved, Siddha, Unani (ASU) products through Quality Council of India.
# Supporting the industry members to participate in various events related to promotion of AYUSH products, medicinal herbs and their value added products exports, including traditional medicines exhibitions such as Vita foods at Geneva and Supply Side West at USA.
# Supporting the industry to organize Reverse Buyer Seller Meet focused to herbals and AYUSH products.
# To enlarge and diversify export production and exports of identified medcicinal plants and herbs through the Export Promotional Council, SHEFEXCIL
# Central Sector Scheme for international Cooperation (IC) of the Ayush Department has been revised to offer incentive to drug manufactures entrepreneurs, AYUSH institutions etc. for participation in international exhibitions, trade fairs, road shows etc and registration of AYUSH products (Market Authorisation) with regulatory bodies of different countries such as USFDA/EMEA/UK-MHRA/NHPD (Canada)/TGA etc. for export of their products.
# In addition, the Department of AYUSH under the IC Scheme establishes AYUSH information Cells in Indian Embassies/Missions to disseminate authentic information about AYUSH aboard; and sets up AYUSH Academic Chairs at international Institutions/Universities. Information Cells have since been set up at Malaysia, Trinidad & Tobago, Mexico, Indonesia, Mauritius, Russia and Hungary; and AYUSH Chairs at University of Western Cape, South Africa an University of West Indies, Trinidad & Tobago.
# MOU are also signed with foreign for cooperation in the field of Traditional Systems of Medicines. Till date MoUs have been signed with Malaysia, Trinidad & Tobago and Hungary. A letter of intent (Lol) has also been signed with Mexico. Download PDF Files
